Diabetes Ther (2018) 9:1413 https://doi.org/10.1007/s13300-018-0423-3 AUTHOR CORRECTION Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study . . . . Alessandro Ciresi Enrica Vigneri Stefano Radellini Felicia Panto` Carla Giordano Published online: April 10, 2018 The Author(s) 2018 Author Correction to: Diabetes Ther (2018) Editorial Assistance. Editorial assistance was 9:363–371 provided by Paolo de Gennaro of Airon Com- https://doi.org/10.1007/ munication. Support for this assistance was s13300-017-0338-4 funded by Novo Nordisk S.p.A. In the original publication, the funding state- ment was incorrectly published and the Edito- Open Access. This article is distributed rial Assistant information was missed in the under the terms of the Creative Commons published version. The correct funding state- Attribution-NonCommercial 4.0 International ment and the Editorial Assistant statement License (http://creativecommons.org/licenses/ should read as below. by-nc/4.0/), which permits any non- Funding. The study and article processing commercial use, distribution, and reproduction charges were funded by Novo Nordisk S.p.A. All in any medium, provided you give appropriate authors had full access to all of the data in this credit to the original author(s) and the source, study and take complete responsibility for the provide a link to the Creative Commons license, integrity of the data and the accuracy of the and indicate if changes were made. data analysis. The original article can be found online at https://doi. org/10.1007/s13300-017-0338-4. A. Ciresi E. Vigneri S. Radellini F. Panto` C. Giordano (&) Section of Endocrinology, Biomedical Department of Internal and Specialist Medicine, University of Palermo, Palermo, Italy e-mail: email@example.com
Diabetes Therapy – Springer Journals
Published: Apr 10, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera